BioCryst Pharmaceuticals
BCRX
#4417
Rank
โ‚น213.47 B
Marketcap
โ‚น851.17
Share price
-0.97%
Change (1 day)
26.52%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚น213.47 Billion

As of March 2026 BioCryst Pharmaceuticals has a market cap of โ‚น213.47 Billion. This makes BioCryst Pharmaceuticals the world's 4417th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น213.47 B47.89%
2025โ‚น144.34 B5.36%
2024โ‚น137.00 B34.14%
2023โ‚น102.13 B-42.33%
2022โ‚น177.09 B-4.53%
2021โ‚น185.49 B92.82%
2020โ‚น96.20 B153.78%
2019โ‚น37.90 B-38.96%
2018โ‚น62.10 B101.31%
2017โ‚น30.85 B-2.76%
2016โ‚น31.72 B-36.93%
2015โ‚น50.30 B-9.28%
2014โ‚น55.45 B99.87%
2013โ‚น27.74 B601.19%
2012โ‚น3.95 B-33.02%
2011โ‚น5.90 B-43.28%
2010โ‚น10.41 B-20.86%
2009โ‚น13.16 B422.41%
2008โ‚น2.51 B-72.64%
2007โ‚น9.20 B-38.51%
2006โ‚น14.97 B-31.05%
2005โ‚น21.71 B298.75%
2004โ‚น5.44 B-2.28%
2003โ‚น5.57 B585.68%
2002โ‚น0.81 B-75.84%
2001โ‚น3.36 B-37.96%
2000โ‚น5.42 B-75.51%
1999โ‚น22.14 B397.23%
1998โ‚น4.45 B17.14%
1997โ‚น3.80 B-52.86%
1996โ‚น8.06 B

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚น213.47 Billion
by Nasdaq info icon info icon
โ‚น213.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚น16.566 T 7,660.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น9.897 T 4,536.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น163.39 B-23.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น620.91 B 190.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น160.21 B-24.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น182.34 B-14.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น2.25 B-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น2.81 B-98.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น39.21 B-81.63%๐Ÿ‡บ๐Ÿ‡ธ USA